| Description |
1 online resource (xvii, 254 pages) : illustrations |
| Series |
ICSA book series in statistics, 2199-0999 |
|
ICSA book series in statistics. 2199-0999
|
| Contents |
Emerging Topics in Dose-Finding and Beyond -- Understanding FDA Guidance On Dosage Optimization For Oncology Therapies -- FDA Project Optimus: The "Paradigm-Shifting" Initiative for Oncology Drug Development -- Challenges and Practical Guidance on the Implementation of Novel Oncology Dose Escalation Designs -- Challenges and Practical Guidance on the Implementation of Novel Oncology Dose Escalation Designs -- Monotonic Dose Response Assumption and Curve-Free Designs for Phase I Dose Finding Trials -- Dose Selection with 2-in-1 Design -- A Rank-Based Approach to Improve the Efficiency of Inferential Seamless Phase 2/3 Clinical Trials with Dose Optimization -- Comparing MCP-MOD and Ordinal Linear Contrast Test in Dose Finding Clinical Trials: A Thorough Examination -- Patient-Reported Tolerability in Drug Development -- Endpoint Development and Validation |
| Bibliography |
Includes bibliographical references |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed November 6, 2024) |
| Subject |
Drug development.
|
|
Drugs -- Dosage.
|
|
Biometry.
|
|
Biometry
|
|
biometrics.
|
| Form |
Electronic book
|
| Author |
Ye, Jingjing, editor
|
|
Chen, Ding-Geng, editor.
|
|
Zhou, Wen, editor
|
|
Deng, Qiqi, editor
|
|
Cappelleri, Joseph C., editor.
|
| ISBN |
9783031671104 |
|
3031671104 |
|
